Evaluation of Revised Indicatons (ERID) for Cochlear Implant Candidacy for the Adult CMS Population

NCT02075229 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2021-07-27

No results posted yet for this study

Summary

Purpose: The purpose of this study is 1) to evaluate the safety and efficacy of currently available multichannel cochlear implant systems for newly implanted adults with an indication based on open-set sentence recognition that expand criteria currently used by Center for Medicare \& Medicaid Services (CMS), and 2) to assess the correlation between measures of speech recognition in candidates for cochlear implants and their utility in predicting audiologic and quality of life outcomes after implantation.

Participants: Adults (≥ 65 years of age) and CMS-eligible as a primary source of medical insurance coverage.

Procedures (methods): Evaluate objective and subjective outcomes of cochlear implantation in a patient population that does not meet current CMS candidacy criteria.

Conditions

  • Bilateral Sensorineural Hearing Loss

Interventions

DEVICE

Cochlear implant

A cochlear implant consists of an implantable device that electrically stimulates surviving nerve fibers within the inner ear to produce perceptions of sound in patients with significant sensorineural hearing loss.. The implanted device is controlled by an external sound processor that converts acoustic sound signals into patterns of electrical stimulation that result in sound perception for the user.

Sponsors & Collaborators

  • University of Michigan

    collaborator OTHER
  • University of Iowa

    collaborator OTHER
  • Johns Hopkins University

    collaborator OTHER
  • University of Miami

    collaborator OTHER
  • NYU Langone Health

    collaborator OTHER
  • University of North Carolina

    collaborator OTHER
  • University of Southern California

    collaborator OTHER
  • Vanderbilt University

    collaborator OTHER
  • University of Washington

    collaborator OTHER
  • Washington University School of Medicine

    collaborator OTHER
  • Loyola University Chicago

    collaborator OTHER
  • University of Pennsylvania

    collaborator OTHER
  • University of Texas

    collaborator OTHER
  • Saint Luke's Health System

    collaborator OTHER
  • Massachusetts Eye and Ear Infirmary

    collaborator OTHER
  • Medical College of Wisconsin

    collaborator OTHER
  • Medical University of South Carolina

    collaborator OTHER
  • Ohio State University

    collaborator OTHER
  • Rocky Mountain Ear Center Audiology and Ear Services

    collaborator UNKNOWN
  • American Cochlear Implant Alliance

    lead OTHER

Principal Investigators

  • Teresa A Zwolan, Ph.D · University of Michigan & American Cochlear Implant Alliance

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02075229 on ClinicalTrials.gov